CONTROLLED SUBSTANCES BOARD
FINDINGS
1. On August 31, 2018, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register placing N-Ethylpentylone into schedule I of the federal Controlled Substances Act. The scheduling action is effective August 31, 2018.
2. The Controlled Substances Board did not receive an objection to similarly treating N-Ethylpentylone as a schedule I under ch. 961, Stats. within 30 days of the date of publication in the federal register of the final order designating N-Ethylpentylone as a controlled substance. 3. The Controlled Substances Board will promulgate a final rule, without making the determinations or findings required by ss. 961.11(1), (1m), (1r) and (2) or s. 961.19 and omitting the notice of proposed rule making, designating N-Ethylpentylone as a schedule I controlled substance. ORDER
Pursuant to s. 961.11(4), Stats., the Controlled Substances Board by affirmative action similarly treats N-Ethylpentylone under chapter 961, Stats. by creating the following: CSB 2.64 Addition of N-Ethylpentylone to schedule I. Section 961.14 (7) (L) 34., Stats., is created to read: 961.14 (7) (L) 34. N-Ethylpentylone, commonly known as ephylone.
This order shall take effect on October 8, 2018 to allow for publication in the Administrative Register. The order expires upon promulgation of a final rule.
Dated October 3, 2018 Doug Englebert, Chair
Controlled Substances Board